Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.40 | 4.00 | 1.25 | 0.31 |
| FCF Yield | 6.77% | 7.45% | 17.33% | 13.63% |
| EV / EBITDA | 5.77 | 3.66 | 3.40 | 3.47 |
| Quality | ||||
| ROIC | 5.76% | 8.51% | 9.12% | 9.51% |
| Gross Margin | 16.70% | 18.79% | 18.76% | 19.17% |
| Cash Conversion Ratio | 1.15 | 0.96 | 1.65 | 1.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.94% | 3.05% | 4.70% | 2.04% |
| Free Cash Flow Growth | -6.50% | -55.92% | 27.08% | 1,616.76% |
| Safety | ||||
| Net Debt / EBITDA | -1.20 | -1.49 | -1.77 | -2.16 |
| Interest Coverage | 8.60 | 10.89 | 11.68 | 11.45 |
| Efficiency | ||||
| Inventory Turnover | 4.88 | 5.33 | 5.39 | 5.34 |
| Cash Conversion Cycle | 79.04 | 69.85 | 115.82 | 69.15 |